Putative assembly | Mammalian 2P channels | Current viewer | |
Last update: 21 / 5 / 2003
Note: All information from various articles is presented including discrepancies.
See my page on the Nomenclature of the K+ channels superfamily
Do not miss the Current viewer !
Names | Oocytes resting potential (mV) | Current at +50 mV (µA) | Conductance (pS) (physiological K+) |
Flickering | Mean open time (ms) | Activation [Tau] |
Inactivation [Tau] |
IV curve in normal K+ | IV curve in symetrical K+ | Names |
KCNK1 (K2p1.1, TWIK-1) |
-76 | 0.5 | 19 (+80 mV) | very | 1.9 (+80 mV) | very rapid | no | Weak inward rectifier | Inward rectifier | KCNK1 (K2p1.1, TWIK-1) |
KCNK2 (K2p2.1, TREK-1) |
-72 | 2 | 48 (+50 mV) | very | . | very rapid | no | Outward rectifier | Saturating at negative potentials | KCNK2 (K2p2.1, TREK-1) |
KCNK3 (K2p3.1, TASK-1, TBAK-1, OAT-1) |
-85 | 2 | 14.6 (-80 mV) 16 (negative potentials) |
yes | 0.8 / 2 (-100 mV) | very rapid | no | Outward rectifier | Linear | KCNK3 (K2p3.1, TASK-1, TBAK-1, OAT-1) |
KCNK4 (K2p4.1, TRAAK, KT4.1) |
-88 | 2 | 46 (positive potentials) | yes | . | very rapid | no | Outward rectifier | Linear | KCNK4 (K2p4.1, TRAAK, KT4.1) |
KCNK5 (K2p5.1, TASK-2) |
-79 | 1.5 | 15 (positive potentials) | very | . | yes [61 ms (+50 mV)] |
. | Outward rectifier | Saturating at negative potentials | KCNK5 (K2p5.1, TASK-2) |
KCNK6 (K2p6.1, TWIK-2, TOSS) |
. | 0.3 | < 5 | . | . | very rapid | yes [218 ms] |
Inward rectifier | Inward rectifier | KCNK6 (K2p6.1, TWIK-2, TOSS) |
KCNK7 | ne | ne | ne | ne | ne | ne | ne | ne | ne | KCNK7 |
KCNK9 (K2p9.1, TASK-3, KT3.2) |
-79 / -93 | 42 / 2.4 | 27 (-100 mV) | yes | 1.1 (-60 mV) | yes [2 / 4 ms (positive potentials)] |
no | Outward rectifier | Outward rectifier | KCNK9 (K2p9.1, TASK-3, KT3.2) |
KCNK10 (K2p10.1, TREK-2) |
-74 | . | 68 / 100 (+40 mV) | yes | 0.9 (-40 mV) | yes | no | Outward rectifier | Linear / Outward rectifier | KCNK10 (K2p10.1, TREK-2) |
KCNK12 (K2p12.1, THIK-2) |
ne | ne | ne | ne | ne | ne | ne | ne | ne | KCNK12 (K2p12.1, THIK-2) |
KCNK13 (K2p13.1, THIK-1) |
. | 20 | . | . | . | yes [0.97 ms] |
no | Outward rectifier | Weak inward rectifier | KCNK13 (K2p13.1, THIK-1) |
KCNK15 (K2p15.1, TASK-5, KT3.3) |
ne | ne | ne | ne | ne | ne | ne | ne | ne | KCNK15 (K2p15.1, TASK-5, KT3.3) |
KCNK16 (K2p16.1, TALK-1) |
-71.9 | 1 | . | . | . | very rapid | no | Outward rectifier | Linear | KCNK16 (K2p16.1, TALK-1) |
KCNK17 (K2p17.1, TALK-2, TASK-4) |
-55.5 | 1 | . | . | . | very rapid | no | Outward rectifier | Saturating at negative potentials | KCNK17 (K2p17.1, TALK-2, TASK-4) |
KCNK18 (K2p18.1, TRESK-1, TRESK-2) |
. | . | . | yes | . | rapid | slow | Outward rectifier | Saturating at negative potentials | KCNK18 (K2p18.1, TRESK-1, TRESK-2) |
Names | Oocytes resting potential (mV) | Current at +50 mV (µA) | Conductance (pS) (physiological K+) |
Flickering | Mean open time (ms) | Activation [Tau] |
Inactivation [Tau] |
IV curve in normal K+ | IV curve in symetrical K+ | Names |
Legend: ne: no expression
Effects of various drugs on the 2P current, tested in physiological K+.
Names | Ba2+ | Gd3+ | Cs+ | TEA | 4-AP | Quinine | Quinidine | Riluzole | CHCl3 | Halothane | Isoflurane | Lidocaïne | Bupivacaïne | Names |
KCNK1 (K2p1.1, TWIK-1) |
. | . | . | . | . | . | . | KCNK1 (K2p1.1, TWIK-1) |
||||||
KCNK2 (K2p2.1, TREK-1) |
/ | / | / | then |
. | . | KCNK2 (K2p2.1, TREK-1) |
|||||||
KCNK3 (K2p3.1, TASK-1, TBAK-1, OAT-1) |
/ | . | . | / | KCNK3 (K2p3.1, TASK-1, TBAK-1, OAT-1) |
|||||||||
KCNK4 (K2p4.1, TRAAK, KT4.1) |
/ | . | . | KCNK4 (K2p4.1, TRAAK, KT4.1) |
||||||||||
KCNK5 (K2p5.1, TASK-2) |
. | . | KCNK5 (K2p5.1, TASK-2) |
|||||||||||
KCNK6 (K2p6.1, TWIK-2, TOSS) |
/ | / | . | . | KCNK6 (K2p6.1, TWIK-2, TOSS) |
|||||||||
KCNK7 | ne | ne | ne | ne | ne | ne | ne | ne | ne | ne | ne | ne | ne | KCNK7 |
KCNK9 (K2p9.1, TASK-3, KT3.2) |
. | . | . | . | . | . | . | KCNK9 (K2p9.1, TASK-3, KT3.2) |
||||||
KCNK10 (K2p10.1, TREK-2) |
. | . | . | / | KCNK10 (K2p10.1, TREK-2) |
|||||||||
KCNK12 (K2p12.1, THIK-2) |
ne | ne | ne | ne | ne | ne | ne | ne | ne | ne | ne | ne | ne | KCNK12 (K2p12.1, THIK-2) |
KCNK13 (K2p13.1, THIK-1) |
. | . | . | . | . | . | . | . | . | . | . | KCNK13 (K2p13.1, THIK-1) |
||
KCNK15 (K2p15.1, TASK-5, KT3.3) |
ne | ne | ne | ne | ne | ne | ne | ne | ne | ne | ne | ne | ne | KCNK15 (K2p15.1, TASK-5, KT3.3) |
KCNK16 (K2p16.1, TALK-1) |
. | . | . | . | KCNK16 (K2p16.1, TALK-1) |
|||||||||
KCNK17 (K2p17.1, TALK-2, TASK-4) |
. | . | . | . | KCNK17 (K2p17.1, TALK-2, TASK-4) |
|||||||||
KCNK18 (K2p18.1, TRESK-1, TRESK-2) |
. | . | . | . | . | . | . | KCNK18 (K2p18.1, TRESK-1, TRESK-2) |
||||||
Names | Ba2+ | Gd3+ | Cs+ | TEA | 4-AP | Quinine | Quinidine | Riluzole | CHCl3 | Halothane | Isoflurane | Lidocaïne | Bupivacaïne | Names |
Legend: ne: no expression, : strong activation, : activation, : no effect, : inhibition, :strong inhibition, . (dot): not tested, /: opposite effects in various studies
Names | PKC | AMPc | [Ca2+]in | Acidic external pH | Alkaline external pH | Acidic internal pH | Alkaline internal pH | Arachidonate | Stretch | Heat | Names |
KCNK1 (K2p1.1, TWIK-1) |
. | . | . | KCNK1 (K2p1.1, TWIK-1) |
|||||||
KCNK2 (K2p2.1, TREK-1) |
KCNK2 (K2p2.1, TREK-1) |
||||||||||
KCNK3 (K2p3.1, TASK-1, TBAK-1, OAT-1) |
/ | / | / | / | KCNK3 (K2p3.1, TASK-1, TBAK-1, OAT-1) |
||||||
KCNK4 (K2p4.1, TRAAK, KT4.1) |
KCNK4 (K2p4.1, TRAAK, KT4.1) |
||||||||||
KCNK5 (K2p5.1, TASK-2) |
/ | . | . | . | KCNK5 (K2p5.1, TASK-2) |
||||||
KCNK6 (K2p6.1, TWIK-2, TOSS) |
/ | / | . | / | / | . | KCNK6 (K2p6.1, TWIK-2, TOSS) |
||||
KCNK7 | ne | ne | ne | ne | ne | ne | ne | ne | ne | ne | KCNK7 |
KCNK9 (K2p9.1, TASK-3, KT3.2) |
. | . | KCNK9 (K2p9.1, TASK-3, KT3.2) |
||||||||
KCNK10 (K2p10.1, TREK-2) |
. | . | KCNK10 (K2p10.1, TREK-2) |
||||||||
KCNK12 (K2p12.1, THIK-2) |
ne | ne | ne | ne | ne | ne | ne | ne | ne | ne | KCNK12 (K2p12.1, THIK-2) |
.KCNK13 (K2p13.1, THIK-1) |
. | . | . | . | . | KCNK13 (K2p13.1, THIK-1) |
|||||
KCNK15 (K2p15.1, TASK-5, KT3.3) |
ne | ne | ne | ne | ne | ne | ne | ne | ne | ne | KCNK15 (K2p15.1, TASK-5, KT3.3) |
KCNK16 (K2p16.1, TALK-1) |
. | . | KCNK16 (K2p16.1, TALK-1) |
||||||||
KCNK17 (K2p17.1, TALK-2, TASK-4) |
. | . | KCNK17 (K2p17.1, TALK-2, TASK-4) |
||||||||
KCNK18 (K2p18.1, TRESK-1, TRESK-2) |
. | . | . | . | KCNK18 (K2p18.1, TRESK-1, TRESK-2) |
||||||
Names | PKC | AMPc | [Ca2+]in | Acidic external pH | Alkaline external pH | Acidic internal pH | Alkaline internal pH | Arachidonate | Stretch | Heat | Names |
Legend: ne: no expression, : strong activation, : activation, : no effect, : inhibition, :strong inhibition, .(dot): not tested, /: opposite effects in various studies
Channel names based on: International Union of Pharmacology (IUPHAR): "Compendium of Voltage-gated Ion Channels", IUPHAR Media Editor
Putative assembly | Mammalian 2P channels | Current viewer | |